| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/08/2001 | CA2383557A1 Vaccine antigens of moraxella |
| 03/08/2001 | CA2383519A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 03/08/2001 | CA2383516A1 Nucleic acid sequences encoding cell wall-degrading enzymes and use to engineer resistance to fusarium and other pathogens |
| 03/08/2001 | CA2383376A1 Flax seed specific promoters |
| 03/08/2001 | CA2383367A1 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 03/08/2001 | CA2383358A1 Methods and compositions of a novel serine protease inhibitor |
| 03/08/2001 | CA2383015A1 Antibodies specific for fullerenes |
| 03/08/2001 | CA2382989A1 Materials and methods for inhibition of ige production |
| 03/08/2001 | CA2382961A1 Zymogen activation system |
| 03/08/2001 | CA2382953A1 Dna encoding the human serine protease c-e |
| 03/08/2001 | CA2382890A1 Gene coding for protein involved in cytokinin signal transduction |
| 03/08/2001 | CA2382889A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | CA2382845A1 Fatty acid desaturase gene from plants |
| 03/08/2001 | CA2382663A1 Uv excitable fluorescent energy transfer dyes |
| 03/08/2001 | CA2382657A1 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks |
| 03/08/2001 | CA2382622A1 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2382383A1 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 03/08/2001 | CA2382381A1 Pa28 modified transgenic mice |
| 03/08/2001 | CA2382324A1 Nucleoside analogues |
| 03/08/2001 | CA2382121A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 03/08/2001 | CA2382120A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 03/08/2001 | CA2382034A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 03/08/2001 | CA2382030A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | CA2381901A1 A plant lecithin:cholesterol acyltransferase-like polypeptide |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2381139A1 Method for the production of a channel forming protein |
| 03/08/2001 | CA2380760A1 New interferon beta-like molecules |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2379994A1 Plant reproduction proteins |
| 03/08/2001 | CA2348158A1 Modified adenoviral fibre and uses thereof |
| 03/08/2001 | CA2317893A1 Production of natural flavors by laccase catalysis |
| 03/08/2001 | CA2308049A1 Diagnostic and therapeutic methods in autoimmune disease |
| 03/08/2001 | CA2303504A1 Diagnostic methods in autoimmune disease |
| 03/07/2001 | EP1081234A2 Apparatus for purifying nucleic acids and proteins |
| 03/07/2001 | EP1081231A1 Method for recovering soluble protein |
| 03/07/2001 | EP1081230A2 Process for producing N-acetyl-neuraminic acid |
| 03/07/2001 | EP1081227A1 Methods and means for retroviral gene delivery |
| 03/07/2001 | EP1081226A1 Apoptin-associating protein |
| 03/07/2001 | EP1081225A1 Transgenic animal model for neurodegenerative diseases |
| 03/07/2001 | EP1081224A1 Novel method for isolating gene |
| 03/07/2001 | EP1081223A1 Promoter sequences expressed in anthers and pollens |
| 03/07/2001 | EP1081221A1 ENDO-$g(b)-N-ACETYLGLUCOSAMINIDASE GENE |
| 03/07/2001 | EP1081163A1 Macromolecular arrays on polymeric brushes and methods for preparing the same |
| 03/07/2001 | EP1080633A1 Method for transforming plant, the resultant plant and gene thereof |
| 03/07/2001 | EP1080371A1 Method and means for caries prevention and susceptibility detection |
| 03/07/2001 | EP1080370A1 Identification of broadly reactive dr restricted epitopes |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080232A2 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE |
| 03/07/2001 | EP1080229A1 Chemically assembled nano-scale devices |
| 03/07/2001 | EP1080226A1 Compositions and methods for topical delivery of oligonucleotides |
| 03/07/2001 | EP1080225A1 Compositions and methods for the pulmonary delivery of nucleic acids |
| 03/07/2001 | EP1080219A1 Amphotropic retrovirus packaging cell line, process for its production and use thereof |
| 03/07/2001 | EP1080218A1 Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient |
| 03/07/2001 | EP1080217A1 Recombinant cytomegalovirus expression system targeting the immediate-early gene region |
| 03/07/2001 | EP1080216A2 Retroviral delivery system |
| 03/07/2001 | EP1080215A1 Mutant herpes simplex viruses and uses thereof |
| 03/07/2001 | EP1080214A2 Cotton cells, plants, and seeds genetically engineered to express insecticidal and fungicidal chitin binding proteins (lectins) |
| 03/07/2001 | EP1080213A1 A process for the selection of transgenic cells in the meristematic region of cotton, coffee, cocoa, banana or grape |
| 03/07/2001 | EP1080212A1 Control of sporocyte or meiocyte formation in plants |
| 03/07/2001 | EP1080211A1 Method of producing thy-a-deficient strains of vibrio cholerae, such strains and their use |
| 03/07/2001 | EP1080210A2 Methods for producing a polypeptide by modifying the copy number of a gene |
| 03/07/2001 | EP1080209A2 Methods of treatment of type 2 diabetes |
| 03/07/2001 | EP1080208A1 Dsrna-mediated regulation of gene expression in plants |
| 03/07/2001 | EP1080207A2 $i(HANSENULA POLYMORPHA) MUTANTS AND PROCESS FOR THE PREPARATION OF RECOMBINANT PROTEINS USING THE SAME |
| 03/07/2001 | EP1080206A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiqitous endoproteases |
| 03/07/2001 | EP1080204A2 Beta-glucosidase coding sequences and protein from orpinomyces pc-2 |
| 03/07/2001 | EP1080203A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
| 03/07/2001 | EP1080202A2 Convection-enhanced delivery of aav vectors |
| 03/07/2001 | EP1080201A2 Novel post-transcriptional regulatory elements and uses thereof |
| 03/07/2001 | EP1080200A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 03/07/2001 | EP1080199A2 (hemorrhagic enteritis) virus dna sequences, proteins encoded thereby and various uses thereof |
| 03/07/2001 | EP1080198A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 03/07/2001 | EP1080197A2 Cell cycle genes, proteins and uses thereof |
| 03/07/2001 | EP1080196A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata |
| 03/07/2001 | EP1080195A1 Endometriosis-associated gene |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080193A2 Multivalent t cell receptor complexes |
| 03/07/2001 | EP1080192A2 Antisense oligonucleotides for treating proliferating cells |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080189A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
| 03/07/2001 | EP1080188A2 Human nucleic acid sequences of uterus myoma tissue |
| 03/07/2001 | EP1080187A2 Modification of cereal grain hardness via expression of puroindoline proteins |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080185A2 Myelin basic protein peptides and uses thereof |
| 03/07/2001 | EP1080182A1 Amino acid modified polypeptides |
| 03/07/2001 | EP1080181A1 clpX OF STREPTOCOCCUS PNEUMONIAE |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080179A2 Purification of cellular components that are substantially rna free |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080110A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 03/07/2001 | EP1080108A1 Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080103A1 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 03/07/2001 | EP1080100A1 Cytosine deaminase gene |
| 03/07/2001 | EP1080099A1 Method and device for purifying nucleic acids |
| 03/07/2001 | EP1080057A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
| 03/07/2001 | EP1079920A1 Device and method for producing a system of chain molecules on a support material |
| 03/07/2001 | EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 03/07/2001 | EP1079861A1 Regulation of biofilm formation |